• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项比较长春碱缓慢静脉输注与静脉推注治疗特发性血小板减少性紫癜的随机试验:42例患者的报告。

A randomized trial comparing vinblastine in slow infusion and by bolus i.v. injection in idiopathic thrombocytopenic purpura: a report on 42 patients.

作者信息

Facon T, Caulier M T, Wattel E, Jouet J P, Bauters F, Fenaux P

机构信息

Service des Maladies du Sang, C.H.U. Lille, France.

出版信息

Br J Haematol. 1994 Mar;86(3):678-80. doi: 10.1111/j.1365-2141.1994.tb04810.x.

DOI:10.1111/j.1365-2141.1994.tb04810.x
PMID:8043455
Abstract

Forty-two patients with ITP were randomly allocated to vinblastine slow infusion or bolus injection. 16/21 patients (76%) receiving slow infusion of vinblastine and 14/21 patients (67%) receiving a bolus injection of vinblastine had a response. There was no superiority of slow infusions of vinblastine over intravenous bolus injections, either when recently diagnosed and chronic ITP were analysed together or separately. In our opinion, intravenous bolus injections of vinblastine might be preferred, because they are easier to perform and have a better local tolerance.

摘要

42例免疫性血小板减少症(ITP)患者被随机分配接受长春碱缓慢输注或大剂量注射。接受长春碱缓慢输注的21例患者中有16例(76%)有反应,接受长春碱大剂量注射的21例患者中有14例(67%)有反应。无论是将新诊断的ITP和慢性ITP一起分析还是分开分析,长春碱缓慢输注并不优于静脉大剂量注射。我们认为,长春碱静脉大剂量注射可能更可取,因为其操作更容易且局部耐受性更好。

相似文献

1
A randomized trial comparing vinblastine in slow infusion and by bolus i.v. injection in idiopathic thrombocytopenic purpura: a report on 42 patients.一项比较长春碱缓慢静脉输注与静脉推注治疗特发性血小板减少性紫癜的随机试验:42例患者的报告。
Br J Haematol. 1994 Mar;86(3):678-80. doi: 10.1111/j.1365-2141.1994.tb04810.x.
2
Slow infusions of vinblastine in the treatment of adult idiopathic thrombocytopenic purpura: a report on 43 cases.长春花碱缓慢输注治疗成人特发性血小板减少性紫癜:43例报告
Blut. 1990 Apr;60(4):238-41. doi: 10.1007/BF01728791.
3
The treatment of adult idiopathic thrombocytopenic purpura. Infusion of vinblastine in ITP.成人特发性血小板减少性紫癜的治疗。长春碱在特发性血小板减少性紫癜中的输注。
Eur J Haematol. 1987 Sep;39(3):193-6. doi: 10.1111/j.1600-0609.1987.tb00756.x.
4
[The combination therapy with vinca-alkaloid slow infusion and cholchicine was effective to refractory idiopathic thrombocytopenic purpura. The patient could receive femoral head replacement in safety].长春花生物碱缓慢输注与秋水仙碱联合治疗对难治性特发性血小板减少性紫癜有效。该患者可安全接受股骨头置换术。
Rinsho Ketsueki. 1996 Feb;37(2):158-60.
5
Treatment of idiopathic thrombocytopenic purpura (ITP) in patients with refractoriness to or with contraindication for corticosteroids and/or splenectomy with immunosuppressive therapy and danazol.对皮质类固醇和/或脾切除术难治或有禁忌证的特发性血小板减少性紫癜(ITP)患者,采用免疫抑制疗法和达那唑进行治疗。
Haematologica. 1993 Nov-Dec;78(6 Suppl 2):29-34.
6
Vinblastine and danazol therapy in steroid resistant childhood chronic idiopathic thrombocytopenic purpura.长春碱与达那唑治疗儿童激素抵抗型慢性特发性血小板减少性紫癜
Int J Hematol. 1995 Apr;61(3):157-62. doi: 10.1016/0925-5710(95)00357-x.
7
Randomized trial of drip infusion versus bolus injection of vinorelbine for the control of local venous toxicity.长春瑞滨静脉滴注与大剂量注射控制局部静脉毒性的随机试验。
Lung Cancer. 2007 Mar;55(3):337-41. doi: 10.1016/j.lungcan.2006.10.016. Epub 2006 Nov 28.
8
Vinblastine in the treatment of children and adolescents with refractory immune thrombocytopenia.长春碱治疗儿童及青少年难治性免疫性血小板减少症
Am J Hematol. 2011 Sep;86(9):785-7. doi: 10.1002/ajh.22081. Epub 2011 Jul 28.
9
Clinical usefulness of vinca alkaloid slow infusion in the treatment of chronic refractory idiopathic thrombocytopenic purpura: a multicenter cooperative study.长春花生物碱缓慢输注治疗慢性难治性特发性血小板减少性紫癜的临床实用性:一项多中心合作研究。
Nihon Ketsueki Gakkai Zasshi. 1990 Feb;53(1):98-104.
10
Phase II study of divided-dose vinblastine in advanced cancer patients.
Tumori. 1989 Jun 30;75(3):248-51. doi: 10.1177/030089168907500311.

引用本文的文献

1
Management of Adult Patients with Immune Thrombocytopenia (ITP): A Review on Current Guidance and Experience from Clinical Practice.成人免疫性血小板减少症(ITP)患者的管理:当前指南及临床实践经验综述
J Blood Med. 2021 Jul 26;12:653-664. doi: 10.2147/JBM.S259101. eCollection 2021.
2
Is dapsone still relevant in immune thrombocytopenia in resource limited settings?在资源有限的环境中,氨苯砜在免疫性血小板减少症中仍具有相关性吗?
BMJ Case Rep. 2019 Dec 19;12(12):e232217. doi: 10.1136/bcr-2019-232217.
3
American Society of Hematology 2019 guidelines for immune thrombocytopenia.
美国血液学会 2019 年免疫性血小板减少症治疗指南。
Blood Adv. 2019 Dec 10;3(23):3829-3866. doi: 10.1182/bloodadvances.2019000966.
4
Updated international consensus report on the investigation and management of primary immune thrombocytopenia.更新的原发性免疫性血小板减少症的调查和管理国际共识报告。
Blood Adv. 2019 Nov 26;3(22):3780-3817. doi: 10.1182/bloodadvances.2019000812.
5
Systematic literature review of treatments used for adult immune thrombocytopenia in the second-line setting.成人二线治疗免疫性血小板减少症的系统文献回顾。
Am J Hematol. 2019 Jan;94(1):118-132. doi: 10.1002/ajh.25301. Epub 2018 Oct 21.
6
Comparison of up-front treatments for newly diagnosed immune thrombocytopenia -a systematic review and network meta-analysis.新诊断的免疫性血小板减少症的一线治疗方法比较——系统评价和网络荟萃分析。
Haematologica. 2018 Jan;103(1):163-171. doi: 10.3324/haematol.2017.174615. Epub 2017 Sep 29.
7
Romiplostim as a treatment for immune thrombocytopenia: a review.罗米司亭治疗免疫性血小板减少症的综述
J Blood Med. 2015 Jan 19;6:37-44. doi: 10.2147/JBM.S47240. eCollection 2015.
8
[Chronic idiopathic thrombocytopenic purpura. Current therapy concept and introduction to pathophysiologic, clinical and diagnostic aspects].[慢性特发性血小板减少性紫癜。当前治疗理念及病理生理、临床和诊断方面介绍]
Med Klin (Munich). 1998 Dec 15;93(12):707-18. doi: 10.1007/BF03044807.
9
The thrombocytopenic purpuras. Recognition and management.血小板减少性紫癜。识别与管理。
Drugs. 1996 Jun;51(6):942-53. doi: 10.2165/00003495-199651060-00003.